Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$0.29 USD
0.00 (1.12%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.29 0.00 (0.28%) 6:28 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
DARE 0.29 0.00(1.12%)
Will DARE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DARE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DARE
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
DARE: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Dare Bioscience, Inc. (DARE) Rating Upgrade to Strong Buy
Dare Bioscience, Inc. (DARE) Upgraded to Buy: What Does It Mean for the Stock?
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Misses Revenue Estimates
Other News for DARE
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Dare Bioscience announces it will receive payment of $1M under grant agreement
Biotech Alert: Searches spiking for these stocks today